¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2023-04-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2023-04-14
±³À°ÀÏÀÚ : 2023-04-14
±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø CMI 1Ãþ ¼­¼ºÈ¯ ¿¬±¸È¦

±³À°ÁÖÁ¦ : 2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇÑ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸

´ã´çÀÚ : °íÇö¹Î
¿¬¶ôó : 02-797-1220

À̸ÞÀÏ : ksgkpt@gmail.com

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 200,000¿ø  

ºñ°í »çÀüµî·Ï) Á¤È¸¿ø- 80,000¿ø ÁØȸ¿ø- 30,000¿ø ºñȸ¿ø- 150,000¿øÇöÀåµî·Ï) Á¤È¸¿ø- 100,000¿ø ÁØȸ¿ø- 50,000¿ø ºñȸ¿ø- 200,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04-14 09:30~10:00 Registration ()

±âŸ 04-14 10:00~10:05 Welcome Address ÇÏÁ¾¿ø(¼­¿ïÀÇ´ë)

±âŸ 04-14 10:05~10:10 Congratulatory address ´ëÇÑ¿Ü°úÇÐȸȸÀå À±µ¿¼·(¿¬¼¼ÀÇ´ë)

±âŸ 04-14 10:10~11:40 Session I. Deceased Donor Kidney Transplantation in KOREA ¹ÚÀç¹ü / ¾ÈÇüÁØ(¼º±Õ°üÀÇ´ë / °æÈñÀÇ´ë)

±³À°½Ã°£ 04-14 10:10~10:40 Current status of DDKT and Kidney Organ Allocation Policy in KOREA ÀüÈ︸(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-14 10:40~11:10 Deceased Donor KT Expanded criteria donor °í¿µ¹Î(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-14 11:10~11:40 Role of Machine perfusion Àå¿ø¹è(Á¦ÁÖÀÇ´ë)

±âŸ 04-14 11:40~13:00 Photo/Lunch ()

±âŸ 04-14 13:00~14:30 Session II. Current immunosuppression in kidney transplantation ¹Ú¼øö / Á¤Ã¶¿õ(°¡Å縯ÀÇ´ë / °í·ÁÀÇ´ë)

±³À°½Ã°£ 04-14 13:00~13:30 Induction immunosuppression in KT À̱³¿ø(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04-14 13:30~14:00 Optimizing trough level and intrapatient variability of tacrolimus in KT ÇѾƶ÷(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-14 14:00~14:30 Clinical usefulness of mTOR(mammalian target of rapamycin) inhibitor in KT ¼Û½Âȯ(ÀÌÈ­ÀÇ´ë)

ÈÞ½Ä 04-14 14:30~15:00 Coffee Break ()

±âŸ 04-14 15:00~16:30 Session III. Kidney transplantation in high immunologic risk recipients Çã±ÔÇÏ / ±è¿µÈÆ(¿¬¼¼ÀÇ´ë / ¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-14 15:00~15:30 Pretransplant immunological risk assessment ¹Ú±Ýº¸·¡(KODA)

±³À°½Ã°£ 04-14 15:30~16:00 Current approach to desensitization and transplant outcomes in ABO/HLA(human leukocyte antigen)-incompatible KT ±ÇÇö¿í(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-14 16:00~16:30 Challenges and limitations of KT in high immunologic risk recipients ÀÌÁÖÇÑ(¿¬¼¼ÀÇ´ë)

±âŸ 04-14 16:30~17:00 Special Session ÇÏÁ¾¿ø(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-14 16:30~17:00 K-NSQIP(National Surgical Quality Improvement Program in Korea) KT ¹Î»óÀÏ(¼­¿ïÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2023-04-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â ´ëÇѱٰñ°Ý¿µ»óÀÇÇÐȸ Á¤±âÇмú´ëȸ 1ÀÏÂ÷ : 2023-04-14
´ÙÀ½±Û ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2023³â º¸ÇàºÐ¼® ¿öÅ©¼¥ : 2023-04-14
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21107 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2024 ºñ´¢»ý½Ä¿µ»óÀÇÇÐ ¿¬¼ö°­Á : 2024-07-07 0 158 2024-06-19
21106 ¼­¿ï 2024³â Çϰ迬¼ö°­Á ¹× Á¦1ȸ ¿¹¹æÁ¢Á¾ ½ÉÆ÷Áö¾ö : 2024-07-07 0 75 2024-06-19
21105 ¼­¿ï Á¦34Â÷ ÀÏÂ÷ÀÇ·áÀÎÀ» À§ÇÑ ³»½Ã°æ ¿¬¼ö°­Á : 2024-07-07 0 88 2024-06-19
21104 ºÎ»ê Á¦6±â ºÎ»ê±¤¿ª½ÃÀÇ»çȸ ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤ : 2024-07-07 0 167 2024-06-19
21103 ´ë±¸ ´ë±¸°æºÏ³»°úÀÇ»çȸ ÇÏ°èÇмú´ëȸ : 2024-07-07 0 158 2024-06-19
21102 ¼­¿ï Á¦17ȸ ¼¼ºê¶õ½º ¾î¸°À̺´¿ø ¼Ò¾Æû¼Ò³âÁúȯ ½ÉÆ÷Áö¾ö : 2024-07-07 0 157 2024-06-19
21101 ¼­¿ï Á¦13ȸ ÁßÀå³â ¿©¼º°Ç°­ ¿¬¼ö°­Á : 2024-06-30 0 83 2024-06-18
21100 ¼­¿ï ´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ Á¦21Â÷ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-06-30 0 23 2024-06-18
21099 ¼­¿ï Á¦ 3ȸ ´ëÇѼҾÆû¼Ò³âÇൿ¹ß´ÞÁõÁø Çмú´ëȸ : 2024-06-30 0 108 2024-06-18
21098 ¼­¿ï 2024 ´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-07 0 79 2024-06-19
21097 ´ëÀü Á¦ 19Â÷ ´ëÀüÃæûÁöȸ Åõ¼®½ÉÆ÷Áö¾ö : 2024-07-07 0 61 2024-06-19
21096 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú Á¦22ȸ ¿À°ø ½ÉÆ÷Áö¾ö : 2024-07-07 0 149 2024-06-19
21095 ºÎ»ê Á¦ 9Â÷ ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ºÎ»ê°æ³²Áöȸ ¿¬¼ö°­Á : 2024-07-07 0 82 2024-06-19
21094 ¼­¿ï Á¦ 2ȸ ´ëÇѼҾƽŰæ¹ß´ÞÇൿ¿¬±¸È¸ Çмú½ÉÆ÷Áö¾ö : 2024-07-07 0 69 2024-06-19
21093 ºÎ»ê (ÇÏÀ̺긮µå) ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ºÎ»ê,¿ï»ê,°æ³²Áöȸ - Á¦2ȸ ¿¬¼ö°­Á : 2024-07-07 0 85 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷